PD1 and PDL1 molecules control suppressor activity of regulatory T cells in chronic Chagas cardiomyopathy patients-Reference-Cited by-同舟云学术

PD1 and PDL1 molecules control suppressor activity of regulatory T cells in chronic Chagas cardiomyopathy patients

Published:2019-07 Issue:7 Volume:80 Page:517-522
ISSN:0198-8859
Container-title:Human Immunology
language:en
Short-container-title:Human Immunology

Author:

Damasio Marcos P.S.,Rocha Manoel O.C.,Sousa Giovane R.,Ferreira Karine S.,Fares-Gusmão Rafaelle C.G.,Medeiros Nayara I.^ORCID,Araujo Fernanda F.,Chaves Ana T.,Dutra Walderez O.,Correa-Oliveira Rodrigo,Gomes Juliana A.S.

Funder

CNPq

FAPEMIG

PAPES

FIOCRUZ

Publisher

Elsevier BV

Subject

General Medicine,Immunology,Immunology and Allergy

Reference26 articles.

1. WHO, Chagas disease (American trypanosomiasis). http://www.who.int/mediacentre/factsheets/fs340/en/.

2. The future of Chagas disease control;Schofield;Trends Parasitol.,2006

3. South-south cooperation for Chagas disease;Salvatella;Lancet,2013

4. Chagas disease;Teixeira;Postgrad. Med. J.,2006

5. Clinical management of chronic Chagas cardiomyopathy;Rocha;Front. Biosci.,2003

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of multifunctional Tregs in cardiovascular disease: From insights into cellular functions to clinical implications;The FASEB Journal;2024-07-09

2. Chagasic cardiomyopathy is marked by a unique signature of activated CD4+ T cells;Journal of Translational Medicine;2022-11-30

3. Prognosis of chronic Chagas heart disease and other pending clinical challenges;Memórias do Instituto Oswaldo Cruz;2022

4. Trypanosoma cruzi Induces Regulatory B Cell Alterations in Patients With Chronic Chagas Disease;Frontiers in Cellular and Infection Microbiology;2021-08-12

5. Could phenothiazine-benznidazole combined chemotherapy be effective in controlling heart parasitism and acute infectious myocarditis?;Pharmacological Research;2020-08